Clinical trial
Alzheimer's Disease Long-term Follow-up Study (ALF Study)
NCT00165724 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alzheimer's Disease Long-term Follow-up Study (ALF Study)
- Lead sponsor
- Eisai Korea Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- December 31, 2006
- Enrollment
- 114 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease